These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17055323)

  • 21. Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness.
    Scheuermeyer FX; Grafstein E; Stenstrom R; Christenson J; Heslop C; Heilbron B; McGrath L; Innes G
    Acad Emerg Med; 2013 Mar; 20(3):222-30. PubMed ID: 23517253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis.
    Lee S; Hess EP; Nestler DM; Bellamkonda Athmaram VR; Bellolio MF; Decker WW; Li JT; Hagan JB; Manivannan V; Vukov SC; Campbell RL
    J Allergy Clin Immunol; 2013 Apr; 131(4):1103-8. PubMed ID: 23453138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between calcium channel blockers and gingival hyperplasia.
    Kaur G; Verhamme KM; Dieleman JP; Vanrolleghem A; van Soest EM; Stricker BH; Sturkenboom MC
    J Clin Periodontol; 2010 Jul; 37(7):625-30. PubMed ID: 20642630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
    Liou YS; Ma T; Tien L; Lin CM; Jong GP
    Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study.
    Michels KB; Rosner BA; Walker AM; Stampfer MJ; Manson JE; Colditz GA; Hennekens CH; Willett WC
    Cancer; 1998 Nov; 83(9):2003-7. PubMed ID: 9806660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Parkinson's Disease and Its Subtypes with Agricultural Pesticide Exposures in Men: A Case-Control Study in France.
    Moisan F; Spinosi J; Delabre L; Gourlet V; Mazurie JL; Bénatru I; Goldberg M; Weisskopf MG; Imbernon E; Tzourio C; Elbaz A
    Environ Health Perspect; 2015 Nov; 123(11):1123-9. PubMed ID: 25815770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study.
    Brauchli YB; Jick SS; Curtin F; Meier CR
    Br J Dermatol; 2008 Jun; 158(6):1299-307. PubMed ID: 18410416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No association between calcium channel blocker use and confirmed bleeding peptic ulcer disease.
    Smalley WE; Ray WA; Daugherty JR; Griffin MR
    Am J Epidemiol; 1998 Aug; 148(4):350-4. PubMed ID: 9717878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular drug prescriptions and risk of depression in diabetic patients.
    Rathmann W; Haastert B; Roseman JM; Giani G
    J Clin Epidemiol; 1999 Nov; 52(11):1103-9. PubMed ID: 10527005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk.
    Powers KM; Smith-Weller T; Franklin GM; Longstreth WT; Swanson PD; Checkoway H
    Parkinsonism Relat Disord; 2006 Apr; 12(3):185-9. PubMed ID: 16364673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of stroke in patients with idiopathic Parkinson disease.
    Becker C; Jick SS; Meier CR
    Parkinsonism Relat Disord; 2010 Jan; 16(1):31-5. PubMed ID: 19640771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pesticide/environmental exposures and Parkinson's disease in East Texas.
    Dhillon AS; Tarbutton GL; Levin JL; Plotkin GM; Lowry LK; Nalbone JT; Shepherd S
    J Agromedicine; 2008; 13(1):37-48. PubMed ID: 19042691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary fats, cholesterol and iron as risk factors for Parkinson's disease.
    Powers KM; Smith-Weller T; Franklin GM; Longstreth WT; Swanson PD; Checkoway H
    Parkinsonism Relat Disord; 2009 Jan; 15(1):47-52. PubMed ID: 18424169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical exposures and Parkinson's disease: a population-based case-control study.
    Frigerio R; Sanft KR; Grossardt BR; Peterson BJ; Elbaz A; Bower JH; Ahlskog JE; de Andrade M; Maraganore DM; Rocca WA
    Mov Disord; 2006 Oct; 21(10):1688-92. PubMed ID: 16773614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β2-adrenoreceptor medications and risk of Parkinson disease.
    Searles Nielsen S; Gross A; Camacho-Soto A; Willis AW; Racette BA
    Ann Neurol; 2018 Nov; 84(5):683-693. PubMed ID: 30225948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary intake of metals and risk of Parkinson's disease: a case-control study in Japan.
    Miyake Y; Tanaka K; Fukushima W; Sasaki S; Kiyohara C; Tsuboi Y; Yamada T; Oeda T; Miki T; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
    J Neurol Sci; 2011 Jul; 306(1-2):98-102. PubMed ID: 21497832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cohort study of antihypertensive medication use and breast cancer among Danish women.
    Fryzek JP; Poulsen AH; Lipworth L; Pedersen L; Nørgaard M; McLaughlin JK; Friis S
    Breast Cancer Res Treat; 2006 Jun; 97(3):231-6. PubMed ID: 16791484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary patterns and risk of Parkinson's disease: a case-control study in Japan.
    Okubo H; Miyake Y; Sasaki S; Murakami K; Tanaka K; Fukushima W; Kiyohara C; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
    Eur J Neurol; 2012 May; 19(5):681-8. PubMed ID: 22136555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of calcium channel blockers in patients with gastrointestinal disease in Japanese community pharmacies.
    Hamada A; Akiyoshi R; Ishii J; Hamada N; Miyazaki C; Hamada T; Ohwaki Y; Ikeda R; Wada M; Nakashima K
    J Clin Pharm Ther; 2012 Feb; 37(1):74-7. PubMed ID: 21395634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.